Table 1. Results of molecular profiling.
| Patient | Sample | Decalcification | Mutation profile |
|---|---|---|---|
| 1 | SR | — | KRAS G12D |
| 2 | SR | — | — |
| 3 | CT | — | EGFR E746_A750del |
| 4 | CT | — | — |
| 5 | SR | — | KRAS G12A |
| 6 | CT | — | — |
| 7 | SR | — | KRAS G12A |
| 8 | SR | — | — |
| 9 | SR | — | — |
| 10 | CT | — | — |
| 11 | CT | — | NCP |
| 12 | CT | — | KRAS G12C |
| 13 | CT | — | KRAS G13D & BRAF D594G |
| 14 | CT | — | KRAS G12C |
| 15 | CT | — | — |
| 16 | CT | — | KRAS G12C |
| 17 | CT | — | — |
| 18 | CT | — | KRAS G12V |
| 19 | CT | — | EGFR E746_A750del |
| 20 | CT | — | KRAS G12V |
| 21 | SR | — | — |
| 22 | SR | — | EGFR L858R & T790M |
| 23 | CT | — | KRAS G12V |
| 24 | CT | — | — |
| 25 | CT | EDTA | EGFR E746_A750del |
| 26 | CT | EDTA | KRAS G12V |
| 27 | CT | EDTA | EGFR L747_P753del |
| 28 | CT | EDTA | KRAS G13D |
| 29 | CT | EDTA | NCP |
| 30 | CT | EDTA | — |
| 31 | CT | EDTA | — |
| 32 | CT | EDTA | NCP |
| 33 | CT | EDTA | — |
| 34 | CT | EDTA | — |
| 35 | CT | EDTA | — |
| 36 | CT | EDTA | KRAS G13D |
| 37 | CT | EDTA | EML4-ALK |
| 38 | CT | EDTA | — |
| 39 | CT | EDTA | EGFR L858R |
| 40 | CT | EDTA | KRAS G12C |
| 41 | CT | EDTA | — |
| 42 | SR | EDTA | — |
| 43 | CT | EDTA | — |
| 44 | CT | EDTA | NP |
| 45 | CT | EDTA | HER2 A775_G776insYVMA |
| 46 | SR | RDO | NI |
| 47 | SR | RDO | NI |
| 48 | CT | RDO | NI |
| 49 | CT | RDO | NI |
Abbreviations: CT, CT-guided biopsy; NCP, not completely performed; NI, not interpretable; NP, not performed; SR, surgery resection.